Delivery Order SPE2DB25D3017-SPE2DB25FVHXF

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,730.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,670,942 units of Methylphenidate ER 18 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of December 10, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $1,223.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566675906 Methylphenidate ER 18 mg tablets in 100-count bottles. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,502,453 units of methylphenidate ER 18 mg tablets in 100-count bottles. The $1,519.44 firm fixed-price Delivery Order (DO) has a completion date of November 21, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,319.97 firm fixed-price delivery order is for the supply of 4,567,193,190 units of Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,483.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4567083512 - Methylphenidate ER 18 mg tablets in quantities of 100, with a performance period ending on January 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,012.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the provision of 4567944679 - Methylphenidate ER 36 mg tablets, a neurological medication. The contract has a firm fixed price and an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,122.84 and is for the supply of Methylphenidate ER 18 mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,370,660 units of methylphenidate ER 18 mg tablets. The firm-fixed-price delivery order, valued at $5,038.82, has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
This federal contract award, valued at $19,295.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,589,791 units of Methylphenidate ER 18 mg tablets in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a performance period ending on December 4, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $2,834.14, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract to supply 4,564,978,922 units of Methylphenidate ER 18 mg tablets, a prescription medication, to the government. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB25D3017
    Indefinite Delivery Contract
  • SPE2DB25D3017-SPE2DB25FVHXF
    Delivery Order

This federal contract award, valued at $1,056.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Methylphenidate ER 18 mg tablets, a prescription medication, with a performance period extending to April 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The current award is not designated as a set-aside contract, indicating open competition.

Generated 7/29/25, 9:46 AM